Company Registry

Qmis LLC
Profile last edited on: 10/25/2021

MRI-based quantitative and automated tools
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

575 West Exchange Street Suite 101
Crete, IL 60417
Multiple Locations:   
Congressional District:   02
County:   Will

Public Profile

QMIS LLC researches and develops MRI-based quantitative and automated tools for improved diagnosis of prostate cancer (PCa). The firm's primary product is MRViPro (MR Virtual Pathology of the Prostate) which provides data based on compartmental analysis of Hybrid-Multidimensional MRI. The product is an image processing software that analyzes data from HM-MRI, a 2D matrix of diffusion-weighted and T2-weighted MRI data. The solution provides Radiologists and researchers with accurate virtual pathology, which is vital for accurate Prostate cancer diagnosis.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2020 1 NIH $225,000
MR Virtual Pathology of the Prostate

Key People / Management

  Aytekin Oto -- CEO

  Aritrick Chatterjee -- Chief Technical Officer

  Elle Hill -- Chief Marketing Officer

  Gregory Karczmar -- Chief Scientific Officer

SBIR firms in the news

There are no news available.